✦ LIBER ✦

Projected risks and costs of cardiovascular disease due to increased systolic blood pressure associated with use of rofecoxib

✍ Scribed by Mason W Russell; Jeffrey D Miller; Douglas C.A Taylor; Daniel M Huse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV2: POPULATION PROJECTIONS OF CARDIOVA

✍ MW Russell; JD Miller; DCA Taylor; DM Huse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Effectiveness and costs of interventions

✍ Christopher JL Murray; Jeremy A Lauer; Raymond CW Hutubessy; Louis Niessen; Niel 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 222 KB

The association between ambulatory systo

✍ Rock, Wasseem; Leshno, Moshe; Shlomai, Gadi; Leibowitz, Avshalom; Sharabi, Yehon 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB

Visit to visit variability of the orthos

✍ Kostis, John B.; Sedjro, Jeanine E.; Kostis, William J.; Cabrera, Javier; Presse 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 337 KB

P2-114: Higher systolic blood pressure w

✍ Sonnen, Joshua A.; Li, Gail; Shofer, Jane B.; Crane, Paul K.; Haneuse, Sebastien 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

The interleukin-6 −174 G/C promoter poly

✍ Humphries, S 📂 Article 📅 2001 🏛 Oxford University Press 🌐 English ⚖ 166 KB